hailir(SH:603639) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-12-04 08:36Core Viewpoint - The company, Hailir Pharmaceutical Group Co., Ltd., is set to hold an investor briefing on December 11, 2025, to discuss its half-year and third-quarter performance for 2025, allowing investors to engage and ask questions about the company's financial results and operational achievements [2][3]. Group 1: Meeting Details - The investor briefing will take place on December 11, 2025, from 14:00 to 15:00 [2][6]. - The location for the meeting is the Shanghai Stock Exchange Roadshow Center, and it will be conducted in an interactive online format [2][4]. - Investors can submit questions from December 4, 2025, to December 10, 2025, before 16:00, either through the Roadshow Center website or via the company's email [5][6]. Group 2: Participants - Key participants in the meeting will include the company's Chairman and General Manager, Mr. Ge Jiacheng, along with the financial head, Mr. Liu Yulong, the board secretary, Ms. Chi Mingming, and independent director, Mr. Yang Aiyi [4]. Group 3: Contact Information - For inquiries, investors can contact Ms. Chi Mingming via phone at 0532-58659169 or through the company's email at hailir@hailir.cn [7]. - After the briefing, the main content and details of the meeting will be available on the Shanghai Stock Exchange Roadshow Center [7].